Weight Health, GLP-1s, and the Gut Connection - Ashley Koff RD on Metabolic Health, Food Noise & Hormones

Weight Health, GLP-1s, and the Gut Connection - Ashley Koff RD on Metabolic Health, Food Noise & Hormones

April 14, 2026 · 1h 7m · Season 1 · Episode 66

About this episode

Dr. Taz and Ashley Koff discuss the broader implications of GLP-1 medications beyond weight loss, focusing on metabolic health and gut connection.

What if weight loss has never been the right goal in the first place? In this episode, Dr. Taz sits down with registered dietitian Ashley Koff, RD, author of Your Best Shot , to unpack why the conversation around GLP-1 medications is much bigger than Ozempic, Wegovy, or tirzepatide alone. This episode reframes the entire GLP-1 conversation by shifting away from weight loss as the goal and toward what Ashley Koff calls “weight health.” Instead of treating Ozempic, Wegovy, tirzepatide, and related medications as magic fixes or villains, the conversation explores the deeper hormonal ecosystem behind appetite, blood sugar, digestion, inflammation, body composition, and metabolic health. Ashley explains that GLP-1 and GIP are part of a larger family of peptide hormones made in the gut lining, and that when this system is disrupted by poor digestion, stress, gut lining damage, nutrient insufficiency, dehydration, medications, or microbiome imbalance, the body’s weight regulation becomes suboptimal. She argues that many people are not failing at weight loss. Their body simply does not have what it needs to function optimally. If you’re dealing with weight changes, food noise, metabolic…

More episodes of hol+ with Dr. Taz MD | The Future of Medicine is Holistic

Explore listener stats, chart rankings, contacts and more on the hol+ with Dr. Taz MD | The Future of Medicine is Holistic podcast page.